Compositions and methods for treating, ameliorating, and/or preventing viral infections
OwnerAnna Marie Pyle, Akiko Iwasaki +1inventors
InventorsAnna Marie Pyle, Akiko Iwasaki, Tianyang Mao
Life of this patent
Estimating the term…
Loading patent…
OwnerAnna Marie Pyle, Akiko Iwasaki +1inventors
InventorsAnna Marie Pyle, Akiko Iwasaki, Tianyang Mao
Estimating the term…
The present disclosure provides small hairpin nucleic acid molecules capable of stimulating interferon production. The nucleic acid molecules of the present disclosure has a double-stranded section of less than 19 base pairs and at least one blunt end. In certain embodiments, the molecule comprises a 5′-triphosphate or a 5′-diphosphate. In certain embodiments, compounds and/or compositions of the disclosure are useful for treating, ameliorating, and/or preventing SARS-CoV-2 viral infection, and/or ameliorating, minimizing, reversing, and/or preventing persistent SARS-CoV-2 viral infection, and/or minimizing or preventing SARS-CoV-2 viral infection-derived mortality and/or lethality, in a subject. In certain embodiments, compounds and/or compositions of the disclosure are useful for treating, ameliorating, and/or preventing SARS-CoV-2 viral infection in a tumor-bearing subject. In certain embodiments, compounds and/or compositions of the disclosure are useful for treating, ameliorating, and/or preventing SARS-CoV-2 viral infection in an immune-compromised and/or immunodeficient subject.
A method for treating, ameliorating, or preventing SARS-CoV-2 viral infection, or ameliorating, minimizing, reversing, or preventing persistent SARS-CoV-2 viral infection, or minimizing or preventing SARS-CoV-2 viral infection-derived mortality or lethality, in a subject,
A method for treating, ameliorating, or preventing SARS-CoV-2 viral infection in a tumor-bearing subject,
A method for treating, ameliorating, or preventing SARS-CoV-2 viral infection in an immune-compromised or immunodeficient subject,
Dependencies are inferred from the claim text.